Healthcare Reform

AFPI Celebrates the End of Human Fetal Tissue in Taxpayer-Funded Research

AFPI applauds the NIH for ending the use of human fetal tissue in taxpayer funded, NIH supported research. Instead, the Trump Administration is advancing innovative technologies to conduct more effective bio medical testing without the cost to unborn life. This decision marks a turning point for gold-standard science in the United States.

Putting Patients First: New Reforms Give Patients Their Money, Their Prices, and More Options

Washington, D.C.—Today, Hannah Anderson, Director of Healthy America Policy and Senior Director of Policy at the America First Policy Institute (AFPI), issued the following statement in response to congressional passage of a government funding package that includes pharmacy benefit manager (PBM) reforms: “This legislation takes an important step towards putting patients—not middlemen—in charge of their healthcare dollars and decisions. For too long, patients have been forced to navigate a system where costs are hidden, competition is distorted, and intermediaries profit. Meanwhile, as PBMs operate in the shadows, the patient has no idea how much of a cut middlemen are receiving from their medication, or that another nearby pharmacy may offer a lower-cost option.

AFPI Urges Congress: Stop Forcing Americans to Pay for Abortions

Today, the America First Policy Institute (AFPI), urged Congress to stop using taxpayer dollars to fund abortions.

Putting Patients First: Hannah Anderson & Dr. Tom Keane on Health Tech

No More Surprise Bills: Hannah Anderson and Mark Atalla on Drug Price Transparency